NCCM
AMED

Nine Chapters Capital Management’s Amedisys AMED Stock Holding History

Nine Chapters Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,300
Closed -$429K – 31
2015
Q3 		$429K Buy
11,300
+300
+3% +$12.7K 0.04% 614
2015
Q2 		$437K Buy
+11,000
New +$343K 0.04% 621
2014
Q3 		– Sell
-11,100
Closed -$186K – 979
2014
Q2 		$186K Buy
+11,100
New +$157K 0.02% 833

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nine Chapters Capital Management's AMED Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Amedisys (AMED) in Q4 2015, closing a stake of 11,300 shares — an estimated $429K sold.

Nine Chapters Capital Management first reported a position in AMED in Q2 2014 and held it in 3 quarters. The position peaked at $437K in Q2 2015. 165 funds tracked by Wall St. Rank hold AMED as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Amedisys position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 11,300 Amedisys shares in Q4 2015, an estimated $429K.
  • Nine Chapters Capital Management first reported a position in Amedisys in Q2 2014 and held it in 3 quarters.
  • Nine Chapters Capital Management's Amedisys position peaked at $437K in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Amedisys as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.